Research and News Involving:
Rare Disease
Adult, AI Validation, Casa Colina Hospital, Chicago, Clinical Trials, Drug, Mayo Clinic, Neurology, Pediatric, Press Release, Rare Disease, University of Texas HSC San Antonio
Press Release: Cures Within Reach Selected Three Clinical Trials in Rare/Ultra-Rare Diseases to Validate AI Predictions Cures Within Reach Selected Three Clinical Trials in Rare/Ultra-Rare Diseases to Validate AI Predictions These clinical trials highlight...
Children's Hospital of Philadelphia, Dr. Teachey, Drug, Early Stage Investigator, Mid-Atlantic, Pediatric, Rare Disease, Success Stories
Repurposing Rapamycin for 6 Autoimmune Childhood Diseases Principal Investigator: Dr. David Teachey Diseases: Autoimmune Lymphoproliferative Syndrome – ALPS; Evans Syndrome; Systemic Lupus Erthematosus; Autoimmune Hemolytic Anemia; Common Variable...
Dr. Rajkumar, Drug, Early Stage Investigator, Mayo Clinic, Oncology, Rare Disease, Success Stories
Thalidomide as a Initial Therapy for Early-Stage Myeloma Principal Investigator: Dr. Vincent Rajkumar Disease: Multiple Myeloma Research Description: In 2002, Cures Within Reach funded Dr. Vincent Rajkumar at Mayo Clinic to test thalidomide, used in leprosy, as a...
Device, Dr. Davalos, Mid-Atlantic, Oncology, Rare Disease, Success Stories, Virginia Tech University
Using an Approved Device to Increase the Immune Response in Pancreatic Cancer Patients Principal Investigator: Dr. Rafael Davalos Diseases: Pancreatic Cancer Research Description: In 2018, Cures Within Reach funded Dr. Rafael Davalos at Virginia Tech University to...
Adult, Current Research, Dr. Lin, Drug, Mayo Clinic, Oncology, Rare Disease
Improving Response to CAR-T Therapy in Multiple Myeloma Principal Investigator: Dr. Yi Lin Disease: Multiple Myeloma Research Description: CAR-T therapy has revolutionized treatment for relapsed refractory multiple myeloma (RRMM), however, it is not curative, and...
Adult, Current Research, Device, Dr. Slade, Early Stage Investigator, Oncology, Rare Disease, Washington University in St. Louis
Improving Access to CAR T with Radiation in Relapsed / Refractory Multiple Myeloma Principal Investigator: Dr. Michael Slade Disease: Multiple Myeloma Research Description: CAR T therapy has significantly extended survival for patients with relapsed or refractory...
Adult, AI Validation, Biologic, Clinical Trials, Drug, Health Equity, LMICs, Neurology, Oncology, Pediatric, Press Release, Rare Disease, Women's Health
Press Release: Cures Within Reach Opens Call to Fund Clinical Trials that Validate AI-Generated Drug-Disease Repurposing Matches Cures Within Reach Opens Call to Fund Clinical Trials that Validate AI-Generated Drug-Disease Repurposing Matches Trials have the potential...
Adult, AI Validation, Clinical Trials, Drug, Health Equity, LMICs, Neurology, Oncology, Pediatric, Press Release, Rare Disease, Women's Health
Press Release: Cures Within Reach Receives Grant from Chan Zuckerberg Initiative to Fund Clinical Trials that Validate AI-Generated Drug-Disease Repurposing Matches Cures Within Reach Receives Grant from Chan Zuckerberg Initiative to Fund Clinical Trials that Validate...
Adult, Clinical Trials, Dr. Hamaluba, Drug, Health Equity, Infectious Disease, KEMRI-Wellcome Trust Research Programme, LMICs, Muhimbili University of Health and Allied Sciences, Neglected Tropical Diseases, Oncology, Press Release, Rare Disease, Women's Health
Press Release: Cures Within Reach and Open Philanthropy Expand Partnership to Address Factors that Lead to High Disease Burden in Low / Lower-Middle Income Countries Cures Within Reach and Open Philanthropy Expand Partnership to Address Factors that Lead to High...
Adult, Baylor College of Medicine, Brown University, Children's National Research Institute, Clinical Trials, Dr. Amorim, Dr. Holder, Dr. Shur, Drug, Health Disparities, Health Equity, Neurology, Oncology, Pediatric, Press Release, Rare Disease, University of California San Francisco
Press Release: Finalists Announced for CureAccelerator Live! for Diversity, Equity & Inclusion Competition Finalists Announced for CureAccelerator Live! for Diversity, Equity & Inclusion Competition Cures Within Reach’s Virtual Pitch Event on October 6...
Adult, Busitema University, Clinical Trials, Dr. Adewole, Dr. Johnson, Dr. Malichewe, Dr. Musaba, Dr. Namazzi, Drug, Global Health Uganda, Health Equity, Infectious Disease, LMICs, Muhimbili University of Health and Allied Sciences, Neglected Tropical Diseases, Obafemi Awolowo University & Teaching Hospitals Complex, Oncology, Press Release, Rare Disease, Université d'Abomey-Calavi, Women's Health
Press Release: Four clinical trials impacting high disease burden in LMICs will start soon Four clinical trials impacting high disease burden in LMICs will start soon Cures Within Reach also announces its latest success story and a multi-year grant from Open...
Adult, Brown University, Chicago, Children's National Research Institute, Clinical Trials, Dr. Amorim, Dr. Holder, Dr. Ibraheem, Dr. Linnstaedt, Dr. Mondal, Dr. Musaba, Dr. Shur, Dr. Wesevich, Dr. Zimba, Drug, Health Disparities, Health Equity, International Centre for Diarrhoeal Disease Research Bangladesh, LMICs, Neglected Tropical Diseases, Neurology, Oncology, Pediatric, Press Release, Rare Disease, ReGRoW, University of California San Francisco, University of Chicago, University of Illinois at Chicago, University of North Carolina Chapel HIll, University of Zambia School of Medicine, Women's Health
Press Release: Eight clinical trials starting soon in health disparities and/or led by underserved researchers Eight clinical trials starting soon in health disparities and/or led by underserved researchers These Diversity, Equity & Inclusion trials funded by...
Patient Impact Awards, Penn Medicine, Press Release, Rare Disease
Press Release: Cures Within Reach Names its 2022 Patient Impact Award Recipients Cures Within Reach Names its 2022 Patient Impact Award Recipients David C. Fajgenbaum, MD, MBA, MSc of Penn Medicine / CDRC and Incyte to be honored in 2022 June 2, 2022 Cures Within...
Adult, Chicago, Cincinnati Children's Hospital Medical Center, Clinical Trials, Device, Drug, Emory University, Health Disparities, Health Equity, LMICs, Neurology, Oncology, Pediatric, Press Release, Rare Disease, Stanford University, University of California Los Angeles, University of Illinois at Chicago, Women's Health
Press Release: Nine clinical trials starting soon in health disparities and/or led by underserved researchers Nine clinical trials starting soon in health disparities and/or led by underserved researchers These Diversity, Equity & Inclusion trials, funded by Cures...
Adult, Children's Hospital of Philadelphia, Clinical Trials, Dr. Fleischman, Dr. Park, Dr. Phillips, Dr. Seif, Drug, Mid-Atlantic, Oncology, Pediatric, Press Release, Rare Disease, Stanford University, University of California Davis, University of California Irvine, University of Michigan
Press Release: Finalists Announced for CureAccelerator Live! for Rare Diseases 2020 Competition Finalists Announced for CureAccelerator Live! for Rare Diseases 2020 Competition Virtual Pitch Event on June 11 Features 5 Clinical Repurposing Projects April 21, 2020...
Adult, Clinical Trials, Dr. Nichols, Drug, Oncology, Pediatric, Press Release, Rare Disease, St. Jude Children's Research Hospital
Press Release: St. Jude Researcher Wins CureAccelerator Live! for Rare Diseases St. Jude Researcher Wins CureAccelerator Live! for Rare Diseases Clinical Trial for Ultrarare Hemophagocytic Lymphohistiocytosis Receives Funding to Repurpose Existing Blood Cancer...
Adult, Clinical Trials, Dr. Nichols, Drug, Oncology, Pediatric, Press Release, Rare Disease, St. Jude Children's Research Hospital
Press Release: Finalists Announced for CureAccelerator Live! for Rare Diseases Competition Finalists Announced for CureAccelerator Live! for Rare Diseases Competition Pitch Event on June 6 in Philadelphia Features 4 Clinical Repurposing Projects April 3, 2019 Cures...
Adult, Children's Hospital of Philadelphia, Clinical Trials, Dr. Fleischman, Dr. Park, Dr. Phillips, Dr. Seif, Drug, Mid-Atlantic, Oncology, Pediatric, Press Release, Rare Disease, Stanford University, University of California Davis, University of California Irvine, University of Michigan
Press Release: University of California, Irvine Researcher Wins CureAccelerator Live! for Rare Diseases University of California, Irvine Researcher Wins CureAccelerator Live! for Rare Diseases Clinical Trial in Myeloproliferative Neoplasms Receives Funding to...
Adult, Brigham Young University, Clinical Trials, Dr. Ghosh, Dr. Ito, Dr. Ohanian, Dr. Romancik, Dr. Watt, Drug, Emory University, Oncology, Pediatric, Press Release, Rare Disease, The University of Texas MD Anderson Cancer Center, University of Michigan, University of Pittsburgh
Press Release: Five clinical trials impacting blood cancers approved for funding Five clinical trials impacting blood cancers approved for funding Cures Within Reach partnered with Goldman Philanthropic Partnerships, Leukemia Research Foundation and individual donors...
Adult, Baylor College of Medicine, Brown University, Children's National Research Institute, Clinical Trials, Dr. Amorim, Dr. Holder, Dr. Shur, Drug, Health Disparities, Health Equity, Neurology, Oncology, Pediatric, Press Release, Rare Disease, University of California San Francisco
Press Release: Brown University and UCSF Researchers Win CureAccelerator Live! for Diversity, Equity & Inclusion Brown University and UCSF Researchers Win CureAccelerator Live! for Diversity, Equity & Inclusion Clinical Repurposing Trials in Bladder Cancer...
